Outlook Therapeutics
OTLK
OTLK
17 hedge funds and large institutions have $865K invested in Outlook Therapeutics in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
39% less capital invested
Capital invested by funds: $1.41M → $865K (-$547K)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$229K | |
| 2 | +$28.1K | |
| 3 | +$23K | |
| 4 |
Barclays
London,
United Kingdom
|
+$21K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$16.5K |
Top Sellers
| 1 | -$59K | |
| 2 | -$26K | |
| 3 | -$23K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$3K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$3K |